GH Research PLC 4

Dermot John Hanley received an award of 2,202 share options in GH Research PLC, representing rights to acquire 2,202 ordinary shares at $0.025 per share.

On August 11, 2026, Dermot John Hanley received a grant of 2,202 share options of GH Research PLC with a strike price of $0.025 per share, classified as an acquisition of derivative securities, which are immediately fully vested but not exercisable until August 11, 2028 and are scheduled to expire on August 11, 2033; upon exercise, these options would convert into an equivalent number of ordinary shares, and following this grant his derivative ownership position reflects 2,202 underlying ordinary shares held indirectly as options. The filing indicates this is a compensatory award rather than an open-market transaction, and no ordinary shares were directly bought or sold on the market in connection with this Form 4.

Filing Facts

CIK

1855129

Ticker

GHRS

Form

4

Source Type

fda

Accession

0001140361-26-032846

Alert Tier

4